Materials used for hemodialysis vascular access: Current strategies and a call to action

Graft

Volumn 6, Issue 1, 2003, Pages 6-15

  Wilhelmi, Mathias ^a   Haverich, Axel ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Arteriovenous; Dialysis; Hemodialysis; Renal end stage disease; Shunt; Vascular access

Indexed keywords

POLITEF;

ARTERIOVENOUS FISTULA; AUTOGRAFT; BLEEDING; CAROTID ARTERY; COST EFFECTIVENESS ANALYSIS; CRYOPRESERVATION; FALSE ANEURYSM; GRAFT INFECTION; GRAFT PATENCY; HEMODIALYSIS; HUMAN; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MORBIDITY; POLITEF IMPLANT; REVIEW; SAPHENOUS VEIN GRAFT; SURVIVAL; THROMBOSIS; UMBILICAL VEIN; VASCULAR ACCESS; VEIN GRAFT; VEIN OCCLUSION;

EID: 0037273266     PISSN: 15221628     EISSN: None     Source Type: Journal    
DOI: 10.1177/1522162802239751     Document Type: Review

References (102)

1. Brescia MJ, Cimino JE, Appel K, et al. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 1966;275:1089-92.
2. Kapoian T, Sherman RA. A brief history of vascular access for hemodialysis: an unfinished story. Semin Nephrol 1997;17:239-45.
3. U.S. Renal Data System. U.S. Renal Data System 1997 annual report. Chap. 10. Washington, DC: U.S. Renal Data System;1997. p. 143-61.
4. Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996;7:523-35.
5. Feldman HI, Held PJ, Hutchinson JT, et al. Hemodialysis vascular access morbidity in the United States. Kidney Int 1993;43:1091-6.
6. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000;58:1758-64.
7. Bloembergen WE, Port FK. Epidemiological perspective on infections in chronic dialysis patients. Adv Ren Replace Ther 1996;3:201-7.
8. Churchill DN, Taylor DW, Cook RJ, et al. Canadian hemodialysis morbidity study. Am J Kidney 1992;19:214-34.
9. Powe NR, Jaar B, Furth SL, et al. Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int 1999;55:1081-90.
10. Kessler M, Hoen B, Mayeux D, et al. Bacteremia in patients on chronic hemodialysis: a multicenter prospective survey. Nephron 1998;64:95-100.
11. Marr Ka, Kong L, Fowler VG, et al. Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. Kidney Int 1998;54:1684-9.
12. Bonomoo RA, Rice D, Whalen C, et al. Risk factors associated with permanent access-site infectins in chronic hemodialysis patients. Infect Control Hosp Epidemiol 1997;18:757-61.
13. Connoly JE, Brownell DA, Levine EF, et al. Comlications of renal dialysis access procedures. Arch Surg 1984;119:1325-8.
14. Munda R, First MR, Alexander JW, et al. Polytetrafluoroethylene graft survival in hemodialysis. JAMA 1983;249:219-22.
15. Schwab SJ, Beathard G. The hemodialysis catheter conundrum: Hate living with them, but can't live without them. Kidney Int 1999;56:1-17.
16. Enzler MA, Rajmon T, Lachat M, et al. Long-term function of vascular access for hemodialysis. Clin Transplant 1996;10:511-5.
17. Kherlakian GM, Roedeerheimer LR, Arbaugh JJ, et al. Comparison of autogeneous fistula versus expanded polytetrafluoroethylene graft fistula for angioaccess in hemodialysis. Am J Surg 1986;152:238-43.
18. Reilly DT, Wood RFM, Bell PFM, et al. Prospective study of dialysis fistulas: problem patients and their treatment. Br J Surg 1982;69:549-53.
19. Palder SB, Kirkman RL, Whittemore AD, et al. Vascular access for hemodialysis: patency rates and results of revision. Ann Surg 1985;202:235-9.
20. Wedgewood KR, Wiggins PA, Guillou PJ. A prospective study of end-to-side vs. side-to-side arteriovenous fistulas for haemodialysis. Br J Surg 1984:71:640-2.
21. Gracz KC, Ing TS, Soung LS, et al. Proximal forearm fisula for maintenance hemodialysis. Kidney Int 1977;11:71-5.
22. Cascaardo S, Acciardo S, Beven EG, et al. Proximal arteriovenous fistulas for haemodialysis when radial arteries are unavailable. Proc Eur Dial Transplant Assoc 1970;7:42-6.
23. Dunlop MG, Mackinlay JY, Jenkins AM. Vascular access: experience with the brachiocephalic fistula. Ann R Coll Surg Engl 1986;68:203-6.
24. Polo JR, Lago M, Goiceochea M, et al. Antecubital arteriovenous fistola for hemodialysis. Nefrologia 1993;13:60-5.
25. Elcheroth J, de Pauw L, Kinneart P. Elbow arteriovenous fistulas for chronic haemodialysis. Br J Surg 1994;81:982-4.
26. Cantelmo NL, LoGerfo FW, Menzoian JO. Brachiobasilic and brachiocephalic fistulas as secondary angioaccess routes. Surg Gynecol Obstet 1982;155:545-8.
27. Kinneart P, Vereerstraeten P, Toussaint C, et al. Nine years' experience with internal arteriovenous fistulas for haemodialysis: a study of some factors influencing the results. Br J Surg 1977;64:242-6.
28. Taylor SM, Eaves GL, Weatheford DA, et al. Results and complications of arteriovenous access dialysis grafts of the lower extremity: a five year review, Am Surg 1996;62:188-91.
29. Rivers SP, Scher LA, Weith FJ. Correction of steal syndrome secondary to hemodialysis access fistulas: a simplified quantitative technique. Surgery 1992;112:593-7.
30. Berman SS, Gentile AT, Glickman MH, et al. Distal revascularization - interval ligation for limb salvage and maintenance of dialysis access in ischemic steal syndrome. J Vasc Surg 1997;26:393-404.
31. Schanzer H, Skladany M, Haimov M. Treatment of angioaccess-induced ischemia by revascularization. J Vasc Surg 1992;16:861-6.
32. Rivers SP, Sche LA, Sheehen E, et al. Basilic vein transposition: an underused autologous alternative to prosthetic dialysis angioaccess. J Vasc Surg 1993;18:391-7.
33. Murphy GJ, White SA, Knight AJ, et al. Long-term results of the transposed autologous brachiocephalic fistula for haemodialysis. Br J Surg 2000;87:819-23.
34. Coburn MC, Carney WI. Comparison of basilic vein and polytetrafluoroethylene for brachial arteriovenous fistuila. J Vasc Surg 1994;20:896-904.
35. Culp K, Taylor L, Hulme PA. Geriatric hemidialysis patients: a comparative study of vascular access. J Am Nephrol Nurses Assoc 1996;23:583-90.
36. Lin SL, Huang CH, Chen HS, et al. Effects of age and diabetes on blood flow rate and primary outcome of newly created hemodialysis arteriovenous fistulas. Am J Nephrol 1998;18:96-100.
37. Ghantous WN, Bailey GL, Zschaeck D, et al. Long-term hemodialysis in the elderly. ASAIO Trans 1971;17:125-8.
38. Rathuas M, Bernheim JL. Are your elderly patients good candidates for dialysis?. Geriatrics 1978;33:56-6.
39. Hakaim AG, Nalbandian M, Scott T. Superior maturation and patency of primary brachiocephalic and transposed basilic vein arteriovenous fistulae in patients with diabetes. J Vasc Surg 1998;27:154-7.
40. Kumpe DA, Cohen MAH. Angioplasty/thrombolytic treatment of failing and failed hemodialysis access site: comparison with surgical treatment. Prog Cardiovasc Dis 1992;34:263-78.
41. Swedburg SH, Brown BG, Sigley R, et al. Intimal fibromuscular hyperplasia at the venous anastomoses of PTFE grafts in hemodialysis patients: clinical, immunocytochemical, light and electron microscopic assessment. Circulation 1989;80:1726-36.
42. Sottiurai VS, Yao JST, Flinn WR, et al. Intimal hyperplasia and neointima: an ultrastructural analysis of thrombosed grafts in humans. Surgery 1983;93:809-17.
43. Davies MG, Hagen PO. Pathobiology of intimal hyperplasia. Br J Surg 1994;81:1254-69.
44. Anderson CB, Gilula LA, Harter HR, et al. Benous angiography and the surgical management of subcutaneous hemodialysis fistulas. Ann Surg 1978;187:194-204.
45. Schwab SJ, Quaarles LD, Middleton JP, et al. Hemodialysis-associated subclavian vein stenosis. Kidney Int 1998;33:1156-9.
46. Sukhatme VP. Vascular access stenosis: prospects for prevention and therapy. Kidney Int 1996;49:1161-74.
47. Dagher FJ, Gelber RL, Ramos EJ, et al. Basilic vein to brachial artery fistula: a new access for chronic hemodialysis. South Med J 1976;69:1438-40.
48. Tokars JI, Miller ER, Alter MJ, et al. Natinal surveillance of dialysis associated diseases in the United States, 1995. ASAIO J 1998;44:98-107.
49. Zibari GB, Gadallah MR, Landreneau M, et al. Preoperative vancomycin prophylaxis decreases incidence of postoperative hemodialysis vascular access infections. Am J Kidney Dis 1997;30:343-8.
50. Raju S. PTFE grafts for hemodialysis access: techniques for insertion manage complications. Ann Surg 1987;206:666-73.
51. Volder JG, Kirkham RL, Kolff WJ. A-V shunts created ni new ways. ASAIO Trans 1973;19:38-42.
52. Schuman ES, Gross GF, Hayes JF, et al. Long-term patency of polytetrafluoroethylene graft fistulas. Am J Surg 1988;644-6.
53. Schwab SJ, Harrington JT, Singh A, et al. Vascular access for hemodialysis. Kidney Int 1999;55:2078-90.
54. Choundhury D, Lee J, Elivera HS, et al. Correlation of venography, venous pressure, and hemoaccess function. Am J Kidney Dis 1995;25:269-75.
55. Berkoben M, Schwab SJ. Maintenance of permanent hemodialysis vascular access patency. J Am Nephrol Nurses Assoc 1995;22:17-24.
56. Hofstra L, Bergmans DC, Leunissen KM, et al. Prosthetic arteriovenous fistula and venous anastomotic stenosis: influence of a high flow velocity on the development of intimal hyperplasia. Blood Purif 1996;14:345-9.
57. Chen C, Lumsden AB, Ofenloch JC, et al. Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model. Ann Vasc Surg 1997;11:74-9.
58. Fortunato JE, Glagov S, Bassiouny HS. Biomechanical factors as regulators of biological responses to vascular grafts. Semin Vasc Surg 1999;12:27-37.
59. Randone B, Cucina A, Graziano P, et al. Suppression of smooth muscle cell proliferation after experimental PTFE arterial grafting: a role for polyclonal anti-basci fibroblast growth factor (bFGF) antibody. Eur J Vasc Endovasc Surg 1998;16:401-7.
60. Almeida JL, Liem TK, Silver D. Heparin-bonded grafts induce platelet aggregation I the presence of heparin-associated antiplatelet antbodies. J Vasc Surg 1998:17:896-900.
61. Kaufmann BR, Fox PL, Graham LM. Platelet-derived growth factor production by canine aortic grafts seeded with endothelial cells. J Vasc Surg 1992;15:699-706.
62. Khadra MH, Dwyer AJ, Thompson JF. Advantages of polytetrafluoroethylene arteriovenous loops in the thigh for hemodialysis access. Am J Surg 1997;173:280-3.
63. Bhandari S, Wilkinson A, Sellars L. Saphenous vein forearm grafts and goretex thigh grafts as alternative forms of vascular access. Clin Nephrol 1995;44:325-8.
64. Rosenberg N, Henderson K, Lord GH, et al. An arterial prosthesis of heterologous vascular origin. J Am Med Ass 19964;187:741-3.
65. Rosenberg N, Martinez A, Sawyer PN, et al. Tanned collagen arterial prosthesis of bovine carotid origin in man: preliminary studies of enzyme-treated heterografts. Ann Surg 1966;164:247-56.
66. Falco RJ. Immunologic studies of untreated and chemically modified bovine carotid arteries. J Surg Res 1970;10:95-100.
67. Hertzer NR, Beven EG. Venous access using the bovine carotid heterograft. Arch Surg 1978;113:696-700.
68. Rolley RT, Sterioff S, Williams GM. Arteriovenous fistulas for dialysis using modified bovine arteries. Surg Gynecol Obst 1976:142:700-4.
69. Sannella NA, Mehgian JT, Pennell JP, et al. Initial approach to blood access for the chronic hemodialysis patient - the bovine heterograft. ASAIO Trans 1976;211;394-6.
70. Butler HG, Baker LD, Hohanson JM. Vascular access for chronic hemodialysis: polytetrafluoroethylene (PTFE) versus bovine heterograft. Hemodialysis 1977;134:791-3.
71. Johansen K, Lyman D, Sauvage L. Biomaterials for hemodialysis access. Blood Purif 1994;12:73-77.
72. Matsuura JH, Johansen KH, Rosenthal D, et al. Cryopreserved femoral vein grafts for difficult hemodialysis access. Ann Vasc Surg 2000;14:50-55.
73. Baraldi A, Bonucchi D, Di Felice A, et al. Liquid nitrogen snap frozen saphenous vein for vascular access in dialysis. ASAIO Trans 1991;37(3):M225-7.
74. Baraldi A, Manenti A, Di Felice A, et al. Absence of rejection in cryopreserved saphenous vein allografts for hemodialysis. ASAIO Trans 1989;37(3):196-7.
75. Bosman PJ, Blankestijn PJ, van der Graaf, et al. A comparison between PTFE and denatured homologous vein grafts for hemodialysis access: a prospective randomised multicentre trial, The SMASH study group, Study of graft materials in access for hemodialysis. Eur J Vasc Endovasc Surg 1998;16:126-32.
76. Harvey R, Bredenberg CE, Couper L, et al. Aspirin enhances platelet-derived growth factor-induced vascular smooth muscle cells. J Vasc Surg 1997;25:689-95.
77. Merrill EX, Salzman EW. Properties of materials affecting the behavior of blood at their surfaces. In: Sawyer PN, editor. Vascular grafts. New York: Appelton-Century-Crofts;1978. p. 119-29.
78. Krause TJ, Robertson FM, Liesch JB, et al. Differential production of interleukin-1 on the surface of biomaterials. Arch Surg 1990;125:1158-60.
79. Back MR, White RA. The biologic response of prosthetic dialysis grafts. In: Wilson SE, editor. Vascular access-principles and practice. St. Louis: Mosby Year Book;1996. p. 137.
80. Sreedhara R, Himmelfarb J, Lazarus JM, et al. Antiplatelet therapy in graft thrombosis: the results of a prospective randomised double blind study. Kidney 1994;45:1477-83.
81. Himmelfrab J, Couper L. Dipyridamole inhibits PDGF and bFGF-induced vascular smooth muscle cell proliferation. Kidney Int 1997;52:1671-7.
82. Madan M, Alexander DJ, McMahon MJ. Influence of catheter type on occurrence of thrombophlebitis during peripheral intravenous nutrition. Lancet 1992;339:101-3.
83. Andrade EA. Blood-materials interactions: 20 years of frustration. Trans Am Soc Artif Internal Organs 1981;27:659.
84. Woodle ES. Surgical versus radiologic intervention for arteriovenous graft thrombosis/stenosis: the case for surgery. In: Henry ML, editor. Vascular access for hemodialysis. Chicago: Precept;1997. p. 53.
85. Trerotola SO. Surgical versus radiologic intervention for arteriovenous graft thrombosis/stenosis: the case for radiology. InL Henry ML, editor. Vascular access for hemodialysis. Chicago: Precept;1997. p. 63.
86. Besarab A, Frinak S, Lubkowski T, et al. Is it time to abondon access recirculation (AR) as a test of access dysfunction? J Am Soc Nephrol 1997;8:153.
87. Mattana J, Effiong C, Kapasi A, et al. Leukocyte-polytetrafluoroethylene interaction enhances proliferation of vascular smooth muscle cells via tumor necrosis factor-a secretion. Kidney Int 1997;52:1478-85.
88. Margiotta MS, Robertson FM, Bijur G, et al. Protein kinase C-mediated inhibition of leukocyte binding to endothelial cells adherent to vascular grafts. Surg Forum 1991;42:360.
89. Windus DW, Atkinson R, Santoro S. The effect of hemodialysis on platelet activation with new and reprocessed regenerated cellulose dialysers. Am J Kidney Dis 1996;27:387-93.
90. Golden MA, Hanson SR, Kirkman TR, et al. Healing of polytetryfluoroethylene arterial grafts is influenced by graft prorsity. J Vasc Surg 1990;11:838.
91. Hirabayaski J, Saitoh E, Ijima H, et al. Influence if fibril length upon ePTFE graft healing and host modification of the implant. J Biomed Mater Pres 1992;26:1433.
92. Palder SB, Kirkman RL, Whittemore AD, et al. Vascular access for hemodialysis: patency rates and results of revision. Ann Surg 1985;202:235-9.
93. Dadrik A, Liu A, Ballerman BJ. Shear stress enhances cell retention and decreases neointimal hyperplasia on endothelial-seeded dialysis grafts. J Am Soc Nephrol 1997;8:155A.
94. Jankowski RJ, Severyn DA, Vorp DA, et al. Effect of retroviral transduction on human endothelial cell phenotype and adhesion to Dacron vascular grafts. J Vasc Surg 1997;26:676-84.
95. Lyman DJ, Knutson K, McNeal B, et al. Effective chemical structure and surface properties of synthetic polymers on the coagulation of blood. IV. The relation between polymer morphology and protein absorption. Trans Am Soc Artif Internal Organs 1975;21:49-60.
96. Grinnel F. Blood materials interactions: absorption of fibronectin. Summary of the Devices and Technology Branch Contractoros Meeting December 1982, NIH Pub. No. 84-1651. National Heart, Lung and Blood Institute 1984:141-2.
97. White RA. Evaluation of small diameter graft parameters using replamine form vascular prostheses. In: Wright CB, editor Vascular grafting. Boston: Wright;1983.
98. Merrill EW. Properties of materials affecting the behavior of blood at their surfaces. Ann N Y Acad Sci 1977;283:6-16.
99. Megerman J, Abbott WM. Compliance in vascular grafts. In: Wright CB, editor. Vascular grafting. Boston: Wright;1983.
100. Shu MCS, Noon GP, Hwang HCS. Flow profiles and wall shear stress distribution at a hemodialysis venous anastoomosis: preliminary study. Biorheology 1987;24:723-35.
101. Helling TS, Nelson PW, Shelton L. A prospective evaluation of plasma TFE and expanded PTFE grafts for routine and early use as vascular access during hemodialysis. Ann Surg 1992;216:596-9.
102. Farmer DL, Goldstine J, Ehrenfeld WK, et al. Failure of glo-discharge polymerization onto woven Dacron to improve performance of hemodialysis graft. J Vasc Surg 1993;18:570-6.